FibroBiologics, Inc. Common Stock

NASDAQ (USD): FibroBiologics, Inc. Common Stock (FBLG)

Last Price

2.95

Today's Change

+0.20 (7.27%)

Day's Change

2.55 - 3.02

Trading Volume

237,097

Overview

Market Cap

103 Million

Shares Outstanding

35 Million

Avg Volume

434,085

Avg Price (50 Days)

2.66

Avg Price (200 Days)

7.09

PE Ratio

-4.92

EPS

-0.60

Earnings Announcement

27-Nov-2024

Previous Close

2.75

Open

2.77

Day's Range

2.552 - 3.0282

Year Range

1.078 - 46.0

Trading Volume

241,408

Price Change Highlight

1 Day Change

7.27%

5 Day Change

2.43%

1 Month Change

-4.53%

3 Month Change

-42.83%

6 Month Change

-68.72%

Ytd Change

-89.86%

1 Year Change

-89.86%

3 Year Change

-89.86%

5 Year Change

-89.86%

10 Year Change

-89.86%

Max Change

-89.86%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment